Search hospitals > North Carolina > Greensboro
Cone Health Cancer Center
Claim this profileGreensboro, North Carolina 27403
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
171 reported clinical trials
3 medical researchers
Summary
Cone Health Cancer Center is a medical facility located in Greensboro, North Carolina. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Cone Health Cancer Center is involved with conducting 171 clinical trials across 190 conditions. There are 3 research doctors associated with this hospital, such as Vinay K. Gudena, Sarah E. Squire, and Ni Gorsuch.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
2Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Vinay K. GudenaCone Health Cancer Center1 year of reported clinical research
Expert in Cancer
Studies Breast Cancer
29 reported clinical trials
64 drugs studied
Sarah E. SquireCone Health Cancer Center5 years of reported clinical research
Studies Brain Tumor
Studies Cancer
1 reported clinical trial
3 drugs studied
Ni GorsuchCone Health Cancer Center4 years of reported clinical research
Studies Endometrial Cancer
Studies Endometrioid Carcinoma
1 reported clinical trial
3 drugs studied
Clinical Trials running at Cone Health Cancer Center
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Squamous Cell Carcinoma
Recurrence
Brain Tumor
ALK Gene Rearrangement
Cognitive Impairment
Oral Cancers
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Cognitive Training
for Breast Cancer Survivors
This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.
Recruiting1 award N/A5 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cone Health Cancer Center?
Cone Health Cancer Center is a medical facility located in Greensboro, North Carolina. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Cone Health Cancer Center is involved with conducting 171 clinical trials across 190 conditions. There are 3 research doctors associated with this hospital, such as Vinay K. Gudena, Sarah E. Squire, and Ni Gorsuch.